Median Technologies SA
PAR:ALMDT

Watchlist Manager
Median Technologies SA Logo
Median Technologies SA
PAR:ALMDT
Watchlist
Price: 1.86 EUR 3.33% Market Closed
Market Cap: 36.2m EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ALMDT stock under the Base Case scenario is 3.67 EUR. Compared to the current market price of 1.86 EUR, Median Technologies SA is Undervalued by 49%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALMDT Relative Value
Base Case
3.67 EUR
Undervaluation 49%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
96
vs Industry
47
Median 3Y
3.4
Median 5Y
5.3
Industry
2.3
Forward
1.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-6.3
Industry
22.1
Forward
-1.7
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-8.3
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-4.9
Industry
20.2
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
0
Median 3Y
-3.5
Median 5Y
-3.5
Industry
2.2
More Details
1.5
EV/S
EV/S
Enterprise Value to Sales
1.5
vs History
96
vs Industry
52
Median 3Y
3.2
Median 5Y
5.1
Industry
2.5
Forward
1.2
More Details
1.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.4
vs History
96
vs Industry
73
Median 3Y
3
Median 5Y
4.9
Industry
5.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-5.6
Industry
11.7
Forward
-1.8
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-5.4
Industry
16.1
Forward
-1.7
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-4
Median 5Y
-7.7
Industry
14.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-7.3
Industry
18.1
More Details
2.1
EV/IC
EV/IC
Enterprise Value to IC
2.1
vs History
96
vs Industry
34
Median 3Y
5
Median 5Y
7.6
Industry
1.9
More Details

Multiples Across Competitors

ALMDT Competitors Multiples
Median Technologies SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Median Technologies SA
PAR:ALMDT
34.3m EUR 1.5 -1.4 -1.6 -1.5
US
Veeva Systems Inc
NYSE:VEEV
47.2B USD 16.5 60.5 50.8 53.4
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
33.5B AUD 175.7 341.1 238.7 238.7
US
Doximity Inc
NYSE:DOCS
11.5B USD 20.1 51.4 43.9 45.9
JP
M3 Inc
TSE:2413
1.3T JPY 4.5 31.8 18.1 21.7
SE
Sectra AB
STO:SECT B
71.4B SEK 34.5 126.7 -156.4 -156.4
US
Waystar Holding Corp
NASDAQ:WAY
6.2B USD 6.4 237.7 21.8 46.7
US
Inspire Medical Systems Inc
NYSE:INSP
3.8B USD 4.5 57.1 58.5 68.8
CN
Winning Health Technology Group Co Ltd
SZSE:300253
23.4B CNY 8.9 305.9 105 105
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
267.1B INR 0 0 0 0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Median Technologies SA
PAR:ALMDT
Average EV/EBITDA: 69.8
Negative Multiple: -1.6 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
50.8
38%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
238.7
38%
6.3
US
Doximity Inc
NYSE:DOCS
43.9
21%
2.1
JP
M3 Inc
TSE:2413
18.1
13%
1.4
SE
Sectra AB
STO:SECT B
Negative Multiple: -156.4 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
21.8
18%
1.2
US
Inspire Medical Systems Inc
NYSE:INSP
58.5
90%
0.7
CN
Winning Health Technology Group Co Ltd
SZSE:300253
105
48%
2.2
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Median Technologies SA
PAR:ALMDT
Average EV/EBIT: 77.9
Negative Multiple: -1.5 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
53.4
39%
1.4
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
238.7
36%
6.6
US
Doximity Inc
NYSE:DOCS
45.9
22%
2.1
JP
M3 Inc
TSE:2413
21.7
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -156.4 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
46.7
40%
1.2
US
Inspire Medical Systems Inc
NYSE:INSP
68.8
64%
1.1
CN
Winning Health Technology Group Co Ltd
SZSE:300253
105
47%
2.2
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A

See Also

Summary
ALMDT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALMDT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALMDT stock valuation using valuation multiples.
Wall Street Estimates
ALMDT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALMDT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 270,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.